|
Sigma-Aldrich has developed an aggressive initiative for the evaluation of novel technologies that can enable the scientific community. This initiative provides Sigma-Aldrich with the opportunity to continue to offer new and novel technology-based products to researchers in academic, medical and industrial institutions, throughout the world.
A core component of the Sigma-Aldrich strategy involves identifying, evaluating and procuring novel technologies. The Sigma-Aldrich Business Development, Technology Transfer and Intellectual Property Management Team plays a key role in implementation of this strategy. This team has negotiated licensing, collaborations, sponsored research and many other types of arrangements with prestigious Universities and Corporations around the world on behalf of the three Sigma-Aldrich Business Divisions. Our goal is to seek out and obtain promising technologies and intellectual property that fit the Sigma-Aldrich business strategy and insure successful achievement of the goals of all participants. The arrangements of interest include: in-licensing, sales and marketing collaborations, product development and commercialization collaborations, partnerships and sponsored research, among many others.
Sigma-Aldrich's achievements in the successful research, development and commercialization of hundreds of new and valuable products each year should make us your first choice as a partner for new technology opportunities.
Please contact the Sigma-Aldrich Business Development Team with novel technology opportunities that target the specific markets below.
Genomics
- Target (Gene) Identification and Validation
- Pathway Analysis
- Genotyping/SNP Detection
- Epigenetics Tools
- Gene Expression Tools and Technologies
Functional Genomics
Vector-based RNAi
- shRNA and siRNA libraries for knockdown in mammalian systems
- Viral delivery technologies
- Delivery targeted to specific cell types
- Inducible expression
- Knockdown cell lines
- cDNA and overexpression libraries
- Enhanced knockdown
Synthetic siRNA
- Novel chemical modification to enhance knockdown, reduce off-target effects and improve stability
- In vivo delivery of siRNA
Other technologies
- Platform technologies for in vivo target validation
- Alternatives to RNAi for studying gene function
- State-of-the-art bioinformatics design tools
- miRNA isolation and quantification
- Tools for studying miRNA and other non-coding RNAs
Cell Biology
- Cellular Assay Platforms
- In vivo Detection and Imaging
- Live Cell Biosensors
Gene Expression
- Fluorescent DNA/RNA Probes
- qRT PCR Reagents
- Multiplex qRT PCR Reagents
Proteomics
- Functional: Arrays, Recombinant Protein Tags, Detection Systems
- Structural: X-ray Crystallography and Post-Translational Modification Analysis
- Quantitative: Tools for Qualitative/Quantitative Differential Analysis and Biomarker Discovery
- Custom peptide libraries
Cell Culture
- Biodisposables
- Reagents that can Upregulate DNA Repair
- Recombinant or Replacement Versions of Growth Factors & Hormones
Analytical
- Analytical Techniques
- Chromatography
- Purification
- Sample Preparation
- Analytical Reagents
- Standards
- Spectroscopy
- Metabolomics
- Analytical Microbiology
Chemical Synthesis
- Asymmetric Synthesis
- Catalysis
- General Synthetic Methods
- Cross-Coupling Chemistry
- Microreactor Technology
Materials Science
- Nanomaterials
- Organic Electronics
- Alternative Energy
- Solid State Synthesis
- Thin Film Deposition
Chemical Biology
- Bioactive small molecule probes and libraries
- Well-characterized and high-purity natural products
- Bioorthogonal reporter technologies
back to Business Development
|
